Patents by Inventor Christopher Peter Worrall

Christopher Peter Worrall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of a purine derivative
    Patent number: 9573951
    Abstract: The present invention relates to new crystalline forms of a purine derivative which exhibits excellent anti-tumor activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline forms.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: February 21, 2017
    Assignee: Cyclacel Limited
    Inventors: Benjamin Mark Skead, Christopher Peter Worrall, Jonathan Charles Christian Atherton, Julian Scott Northen, Philippe Fernandes
  • Kinase inhibitor polymorphs
    Patent number: 9403820
    Abstract: Polymorphs of chemical compounds that modulate kinase activity, including PI3K activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3K activity, are described herein.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: August 2, 2016
    Assignees: Intellikine LLC, Sigma-Aldrich Company Limited
    Inventors: Pingda Ren, Michael Martin, Christopher Peter Worrall, Susanna del Rio Gancedo
  • CRYSTALLINE FORMS OF A PURINE DERIVATIVE
    Publication number: 20150148354
    Abstract: The present invention relates to new crystalline forms of a purine derivative which exhibits excellent anti-tumour activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline forms.
    Type: Application
    Filed: October 27, 2014
    Publication date: May 28, 2015
    Inventors: Benjamin Mark SKEAD, Christopher Peter WORRALL, Jonathan Charles Christian ATHERTON, Julian Scott NORTHEN, Philippe FERNANDES
  • KINASE INHIBITOR POLYMORPHS
    Publication number: 20150005301
    Abstract: Polymorphs of chemical compounds that modulate kinase activity, including PI3K activity, and chemical compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3K activity, are described herein.
    Type: Application
    Filed: November 12, 2012
    Publication date: January 1, 2015
    Inventors: Pingda Ren, Michael Martin, Christopher Peter Worrall, Susanna del Rio Gancedo
  • Crystalline forms of a purine derivative
    Patent number: 8889861
    Abstract: The present invention relates to new crystalline forms of a purine derivative which exhibits excellent anti-tumour activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline forms.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: November 18, 2014
    Assignee: Cyclacel Limited
    Inventors: Benjamin Mark Skead, Christopher Peter Worrall, Jonathan Charles Christian Atherton, Julian Scott Northen, Philippe Fernades
  • CRYSTALLINE FORMS OF A PURINE DERIVATIVE
    Publication number: 20130072504
    Abstract: The present invention relates to new crystalline forms of a purine derivative which exhibits excellent anti-tumour activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and use thereof in the prevention or treatment of disease. The invention further relates to a process for preparing the crystalline forms.
    Type: Application
    Filed: January 24, 2011
    Publication date: March 21, 2013
    Applicant: CYCLACEL LIMITED
    Inventors: Benjamin Mark Skead, Christopher Peter Worrall, Jonathan Charles Christian Atherton, Julian Scott Northen, Philippe Fernades
  • Cycloalkanone derivatives
    Publication number: 20030080321
    Abstract: The invention relates to compounds of formula I 1
    Type: Application
    Filed: April 5, 2002
    Publication date: May 1, 2003
    Applicant: MERCK KGAA
    Inventors: Louise Diane Farrand, Christopher Peter Worrall, Owain Llyr Parri, Ian Victor Edward Hassal, Julian Frederick Samuel Vaughan-Spickers